Next Article in Journal
Significant Leukocytosis with Hypereosinophilia Secondary to Trichuris trichiura in Adult: A Case Report
Previous Article in Journal
Regurgitation under the ERAS Program: A Case Report
Review

Analysis of the Delta Variant B.1.617.2 COVID-19

1
Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 E 2nd St, Pomona, CA 91766, USA
2
Department of Biology, University of California Irvine, Irvine, CA 92697, USA
*
Author to whom correspondence should be addressed.
Clin. Pract. 2021, 11(4), 778-784; https://doi.org/10.3390/clinpract11040093
Received: 24 September 2021 / Revised: 14 October 2021 / Accepted: 15 October 2021 / Published: 21 October 2021
With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As of August 2021, the delta variant has quickly become the dominant strain. Despite countries like the US, where most of the population is vaccinated, COVID-19 has made a resurgence in infections. Collectively, as a country, we ask: is it more deadly? What makes it more “contagious” or “transmissible”? This review article delves into the information we already know about the delta variant and how it compares with the other SARS-CoV-2 variants. The current vaccine companies like AstraZeneca, Pfizer/BioNTech, and Moderna have reported that their vaccines can provide protection against this variant but with a slightly reduced efficacy. In this article, we do a comprehensive review and summary of the delta B.1.617.2 variant and what makes it more contagious. View Full-Text
Keywords: COVID-19; delta variant; B.1.617.2 COVID-19; delta variant; B.1.617.2
Show Figures

Figure 1

MDPI and ACS Style

Shiehzadegan, S.; Alaghemand, N.; Fox, M.; Venketaraman, V. Analysis of the Delta Variant B.1.617.2 COVID-19. Clin. Pract. 2021, 11, 778-784. https://doi.org/10.3390/clinpract11040093

AMA Style

Shiehzadegan S, Alaghemand N, Fox M, Venketaraman V. Analysis of the Delta Variant B.1.617.2 COVID-19. Clinics and Practice. 2021; 11(4):778-784. https://doi.org/10.3390/clinpract11040093

Chicago/Turabian Style

Shiehzadegan, Shayan, Nazanin Alaghemand, Michael Fox, and Vishwanath Venketaraman. 2021. "Analysis of the Delta Variant B.1.617.2 COVID-19" Clinics and Practice 11, no. 4: 778-784. https://doi.org/10.3390/clinpract11040093

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop